SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-000970
Filing Date
2019-08-29
Accepted
2019-08-29 16:30:53
Documents
14
Period of Report
2019-08-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv528546_8k.htm   iXBRL 8-K 23163
2 EXHIBIT 99.1 tv528546_ex99-1.htm EX-99.1 24669
6 GRAPHIC tv528546_ex99-1img01.jpg GRAPHIC 16569
  Complete submission text file 0001410578-19-000970.txt   249000

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA espr-20190829.xsd EX-101.SCH 3187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20190829_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20190829_pre.xml EX-101.PRE 21959
15 EXTRACTED XBRL INSTANCE DOCUMENT tv528546_8k_htm.xml XML 3615
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 191066735
SIC: 2834 Pharmaceutical Preparations